Cargando…
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
In recent years, the evolution of treatments has made it possible to significantly improve the outcomes of patients with non-small cell lung cancer (NSCLC). In particular, while molecular targeted therapies are effective in specific patient sub-groups, immune checkpoint inhibitors (ICIs) have greatl...
Autores principales: | Rossi, Giovanni, Russo, Alessandro, Tagliamento, Marco, Tuzi, Alessandro, Nigro, Olga, Vallome, Giacomo, Sini, Claudio, Grassi, Massimiliano, Dal Bello, Maria Giovanna, Coco, Simona, Longo, Luca, Zullo, Lodovica, Tanda, Enrica Teresa, Dellepiane, Chiara, Pronzato, Paolo, Genova, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281184/ https://www.ncbi.nlm.nih.gov/pubmed/32365882 http://dx.doi.org/10.3390/cancers12051125 |
Ejemplares similares
-
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021) -
Classification of Allergic Rhinitis: What is Most Suitable in Korea?
por: Dhong, Hun-Jong
Publicado: (2013) -
On the most suitable sites for wind farm development in Nigeria
por: Ayodele, T.R., et al.
Publicado: (2018) -
Which Are the Most Suitable Stents for Interventional Endoscopic Ultrasound?
por: Park, Se Woo, et al.
Publicado: (2020) -
Septoplasty alone is not suitable for most structural nasal obstructions
por: Liu, Jin-Feng, et al.
Publicado: (2020)